Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALOREVA: Allogenic ASCs for rectovaginal fistula in Crohn's disease
NCT00999115Phase 2Completed
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Sep 2009
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
Phase 2, open-label trial of darvadstrocel in rectovaginal fistula (RVF), sponsored by Hospital La Paz Institute for Health Research. Primary endpoint: Percentage of subjects in whom the external openings of the treated rectovaginal fistula have closed at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
darvadstrocel
03
Conditions
rectovaginal fistula (RVF)
Beyond the preview
Go deeper on NCT00999115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999115.